Wendy Miyuki Whiteside, MD

Dr. Whiteside is Associate Director of Pediatric Interventional Cardiology at the University of Michigan Congenital Heart Center. As an interventional cardiologist, she performs minimally invasive diagnostic and interventional cardiac catheterization procedures on infants, children, and adults with congenital heart disease.

Dr. Whiteside received her undergraduate degree in biology from Washington University in St. Louis in 2002. She went on to receive her MD from Albert Einstein College of Medicine in New York in 2006 and completed her general pediatric residency at Children’s Hospital and Research Center Oakland in Oakland, CA in 2009. Prior to beginning cardiology fellowship, she was a Clinical Instructor in the Cardiovascular Intensive Care Unit at Lucille Packard Children’s Hospital at Stanford University in Palo Alto, CA. She then completed her general pediatric cardiology fellowship at the University of Michigan Congenital Heart Center in Ann Arbor, MI in 2013. She remained at the University of Michigan as a Clinical Instructor to complete fellowship training as a pediatric interventional cardiologist. After spending 3 years as an Interventional Cardiologist at Cincinnati Children’s Hospital Medical Center, Dr. Whiteside returned to the University of Michigan Congenital Heart Center as faculty in 2017 where she is an Interventional Cardiologist in the Congenital Cardiac Catheterization Laboratory and attends on the general cardiology/surgical service. Dr. Whiteside’s clinical and research interests include quality improvement in the catheterization lab and across the Congenital Heart Center, and complex transcatheter procedures including pulmonary valve replacement in children and adults, interventions on small neonates including PDA occlusion and outflow tract stenting, and hybrid and fetal interventions. 

Congenital Heart Disease, Pediatric Interventional Cardiology

University of Michigan Health participates with most health insurance plans.

My research interests include quality improvement within the cardiac catheterization lab (including participation in the national cardiac catheterization registries-- IMPACT and C3PO), congenital heart disease and catheterization outcomes research, and involvement in new device trials.